News
The health sector is witnessing notable developments. Bristol Myers and Pfizer are offering Eliquis at a discounted rate.
Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...
10d
Zacks Investment Research on MSNJNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified ...
The healthcare industry offers many attractive dividend investments. Both Johnson & Johnson as well as Pfizer have a positive outlook.
The CDC has approved eligibility guidelines for the Pfizer vaccine booster. Recommendations for Moderna and Johnson & Johnson could come soon.
Comparing the COVID-19 vaccines: If you have a choice, which one should you get? Pfizer, Moderna and Johnson & Johnson are all safe and effective, but there are some differences.
CDC recommends Pfizer, Moderna vaccines over Johnson & Johnson, citing rare blood-clot issue Nine deaths, several dozen cases, have been confirmed in connection with the vaccine.
Health experts say not to hold out for a certain vaccine. But Pfizer, Moderna and Johnson & Johnson doses are available in Illinois. Can you choose?
Johnson & Johnson's vaccine won't capture nearly as much market share as Pfizer and Moderna this year. The company's vaccine has been at a disadvantage due to a perceived lower efficacy rate.
According to medical experts, the Johnson & Johnson, Pfizer and Moderna COVID vaccines each offer some level of protection, but how do they compare to each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results